APA

Rollema H., Hajós M., Seymour P. A., Kozak R., Majchrzak M. J., Guanowsky V., Horner W. E., Chapin D. S., Hoffmann W. E., Johnson D. E., McLean S., Freeman J. & Williams K. E. (20090921). Preclinical pharmacology of the alpha4beta2 nAChR partial agonist varenicline related to effects on reward, mood and cognition. : Biochemical pharmacology.

Chicago

Rollema Hans, Hajós Mihály, Seymour Patricia A, Kozak Rouba, Majchrzak Mark J, Guanowsky Victor, Horner Weldon E, Chapin Doug S, Hoffmann William E, Johnson David E, McLean Stafford, Freeman Jody and Williams Kathryn E. 20090921. Preclinical pharmacology of the alpha4beta2 nAChR partial agonist varenicline related to effects on reward, mood and cognition. : Biochemical pharmacology.

Harvard

Rollema H., Hajós M., Seymour P. A., Kozak R., Majchrzak M. J., Guanowsky V., Horner W. E., Chapin D. S., Hoffmann W. E., Johnson D. E., McLean S., Freeman J. and Williams K. E. (20090921). Preclinical pharmacology of the alpha4beta2 nAChR partial agonist varenicline related to effects on reward, mood and cognition. : Biochemical pharmacology.

MLA

Rollema Hans, Hajós Mihály, Seymour Patricia A, Kozak Rouba, Majchrzak Mark J, Guanowsky Victor, Horner Weldon E, Chapin Doug S, Hoffmann William E, Johnson David E, McLean Stafford, Freeman Jody and Williams Kathryn E. Preclinical pharmacology of the alpha4beta2 nAChR partial agonist varenicline related to effects on reward, mood and cognition. : Biochemical pharmacology. 20090921.